Dept for Hematopoetic Transplantations, MED3, University of Munich, Germany.
VironPearl Biotech GmbH, Munich, Germany.
Cell Immunol. 2018 Jun;328:33-48. doi: 10.1016/j.cellimm.2018.03.005. Epub 2018 Mar 16.
Paramunity-inducing-Factors (PINDs) consist of attenuated/inactivated viruses of various poxvirus-genera, used in veterinary medicine as non-antigen-specific, non-immunising stimulators of the innate immune system against infectious and malignant diseases. Their danger-signaling-interactions were tested for their capacity to improve leukemic antigen-presentation on DC generated from AML-patients' blasts ('DC') and DC-stimulation/activation of antileukemic T-cells.
We analyzed, whether the addition of PINDs during DC cultures (15 healthy, 22 leukemic donors) and mixed lymphocyte culture (MLC, n = 15) with autologous (n = 6), allogeneic (n = 2) or T-cells after stem cell transplantation (SCT; n = 7) would alter the quality and quantity of DC, the composition of T-cell-subsets, and/or their antileukemic functionality (AF) as studied by FACS and functional Fluorolysis-cytotoxicity-assays.
Effects on 1. DC-cultures: PINDs in DC-cultures lead to increased proportions of mature DC and DC, but reduced proportions of viable and overall, as well as TLR4- and TLR9-expressing DC. 2. MLC: PINDs increased early (CD8+) T-cell activation (CD69+), but reduced proportions of effector-T-cells after MLC 3. AF: Presence of PINDs in DC- and MLC-cultures reduced T-cells' as well as innate cells' antileukemic functionality. 4. Cytokine-release profile: Supernatants from PIND-treated DC- and MLC-cultures resembled an inhibitory microenvironment, correlating with impaired blast lysis.
Our data shows that addition of PINDs to DC-cultures and MLC result in a "blast-protective-capacity" leading to impaired AF, likely due to changes in the composition of T-/innate effector cells and the induction of an inhibitory microenvironment. PINDs might be promising in treating infectious diseases, but cannot be recommended for the treatment of AML-patients due to their inhibitory influence on antileukemic functionality.
免疫原性诱导因子(PINDs)由各种痘病毒属的减毒/灭活病毒组成,在兽医医学中作为非抗原特异性、非免疫刺激物,用于刺激针对传染病和恶性疾病的固有免疫系统。测试了它们的危险信号相互作用,以评估其改善急性髓细胞白血病(AML)患者的原始细胞生成的树突状细胞(DC)上白血病抗原呈递的能力,以及对白血病 T 细胞的 DC 刺激/激活作用。
我们分析了在 DC 培养过程中(15 名健康供体,22 名白血病供体)和混合淋巴细胞培养(MLC,n=15)中添加 PINDs 是否会改变 DC 的质量和数量、T 细胞亚群的组成,以及它们的抗白血病功能(AF),研究方法是通过流式细胞术和功能荧光溶解细胞毒性测定。
我们的数据表明,在 DC 培养物和 MLC 中添加 PINDs 会导致“原始细胞保护能力”,从而导致 AF 受损,这可能是由于 T/先天效应细胞组成的变化以及诱导抑制性微环境所致。PINDs 在治疗传染病方面可能很有前景,但由于其对抗白血病功能的抑制作用,不能推荐用于治疗 AML 患者。